Louisiana AG, Health Centers Defend 340B Contract Pharmacy Law in Response to Drugmaker Suit

Louisiana Attorney General Liz Murrill (R) and a state provider group each filed response briefs to drugmaker AbbVie in a case challenging Louisiana's 340B contract pharmacy access law.
Louisiana Attorney General Liz Murrill (R) and a state provider group each filed response briefs to drugmaker AbbVie in a case challenging Louisiana's 340B contract pharmacy access law.
Louisiana’s 340B contract pharmacy access law is constitutional because it governs drug distribution and not pricing, a state official and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Instead of Dismissing Medicare Advantage 340B Case, Judge Allows Hospitals to Amend

Humana's request to dismiss an Alabama health system's Medicare Advantage lawsuit was denied by a federal judge.
A federal judge denied health insurer Humana’s request to dismiss an Alabama health system’s suit against its Medicare Advantage plans [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Twenty-One Percent of 340B Hospitals Will Not Receive Lump Sum Payments: Research

A JAMA research letter found that one-fifth of 340B hospitals will not receive repayment from Medicare for previous underpayments.
One-fifth of 340B hospitals will garner no repayment from Medicare for past underpayments, according to a recent analysis by a [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Cosette Pharmaceuticals Offers 340B Provider Refunds on 38 Drugs

North Carolina-based drug manufacturer Cosette will refund 340B providers for 38 medications.
Cosette Pharmaceuticals recently announced refunds to 340B covered entities for 38 medications sold over a year and half. The refunds [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Bausch Health Becomes 22nd Drugmaker to End or Loosen 340B Contract Pharmacy Restrictions in Arkansas

Drugmaker Bausch Health has exempted all Arkansas covered entities from its 340B contract pharmacy restrictions in response to a state law recently upheld by a federal appeals court.
Drug manufacturer Bausch Health announced it will exempt all Arkansas providers and pharmacies from its 340B contract pharmacy policy, including [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

CBO Recommendation: Restrict 340B Access to Get Hospitals to Join ACOs

The Congressional Budget Office report recommended restricting 340B access to incentivize hospitals to join accountable care organizations.
As part of a report on incentivizing use of accountable care organizations (ACOs), Congress’ primary research arm recently recommended excluding [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Attorneys Expect Many Filings under Newly Reconstituted 340B Dispute Resolution Process

Kyle Vasquez, an attorney for Polsinelli, said he expects a "wave of filings" under HRSA's latest ADR rule because it is more flexible than the prior process.
Attorneys for both covered entities and drug manufacturers say they expect a significant number of filings to the newly re-established [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Maine Issues Draft Rule for 340B Hospital Reporting Requirements with New Data, Enforcement Provisions

After Maine passed one of the nation's first 340B provider reporting laws last year, a state health agency has proposed a rule for implementation.
The state agency tasked with implementing Maine’s state 340B hospital reporting requirement has proposed a rule with additional data and [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novartis to Refund Covered Entities After Adjusting 340B Ceiling Prices for 100-Plus Products

Drugmaker Novartis filed suit to block Maryland's recently signed 340B contract pharmacy statute.
Thousands of covered entities that purchased more than one hundred Novartis products between late 2019 and early 2023 will be [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Providers Generally Supportive, PhRMA Pans Final 340B Dispute Resolution Rule

After HHS released the long-awaited final rule for resolving 340B administrative disputes, provider groups generally supported and PhRMA denounced the updated process.
Provider advocates celebrated—with some reservations—the recently issued final rule reshaping the Administrative Dispute Resolution (ADR) process for 340B stakeholders. On [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live